{"id":388,"date":"2025-11-04T23:59:23","date_gmt":"2025-11-04T16:59:23","guid":{"rendered":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/"},"modified":"2025-11-04T23:59:23","modified_gmt":"2025-11-04T16:59:23","slug":"kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan","status":"publish","type":"post","link":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/","title":{"rendered":"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan"},"content":{"rendered":"
\n

Kimberly\u2011Clark mengatakan pada 3 November 2025 bahwa pihaknya berencana mengakuisisi Kenvue, bekas unit Johnson & Johnson dan pembuat merek besar Amerika Serikat seperti Band-Aid dan Tylenol, dengan nilai sekitar $48,7 miliar (1).<\/p>\n

Segera setelah pengumuman tersebut, saham Kimberly-Clark merosot tajam; Kenvue punya berada di garis bidik<\/astro-island> Menteri Kesehatan dan Layanan Kemanusiaan AS Robert F. Kennedy Jr. atas dugaan adanya hubungan antara penggunaan asetaminofen\u2014bahan aktif dalam Tylenol\u2014oleh wanita hamil, dan prevalensi gangguan spektrum autisme dan\/atau gangguan hiperaktif defisit perhatian pada anak-anak (1,2).<\/p>\n

\u201cHal ini memvalidasi bagaimana ekspektasi pelonggaran suku bunga memicu merger besar-besaran yang bersifat transformasional,\u201d Kimberly Forrest, kepala investasi di Bokeh Capital Partners, mengatakan kepada Reuters<\/astro-island> (1). “Kedua perusahaan tersebut berada berdampingan di rak-rak toko, sehingga skala dan logika distribusinya masuk akal meskipun produk Tylenol tetap menjadi bayangan yang sebaiknya dihindari oleh pembeli mana pun.”<\/p>\n

Berikut adalah beberapa pertimbangan penting lainnya dari kesepakatan ini bagi para profesional industri farmasi:<\/p>\n

Apa yang terjadi dengan sumber daya hulu portofolio merek?<\/strong><\/h2>\n

Portofolio produk perusahaan hasil merger yang besar berarti pengadaan bahan aktif, eksipien, dan bahan pengemas di hulu dapat berubah secara signifikan, sehingga berdampak pada pemasok yang melayani pasar kesehatan konsumen dan farmasi.<\/p>\n

Bagaimana hal ini dapat mempengaruhi toleransi risiko peraturan?<\/strong><\/h2>\n

Litigasi yang melibatkan Kenvue akibat klaim acetaminophen-autisme telah menyoroti bagaimana produk kesehatan yang dikonsumsi konsumen pun membawa risiko peraturan dan reputasi (1). Tuntutan kepatuhan dapat meningkat seiring dengan kaburnya batas-batas sektor.<\/p>\n

Apakah jejak manufaktur akan terkonsolidasi atau terdiversifikasi?<\/strong><\/h2>\n

Dengan sinergi biaya yang ditargetkan dan manfaat integrasi yang disebutkan dalam transaksi, lokasi manufaktur untuk produk kesehatan konsumen dan produk farmasi dapat dikonsolidasikan atau digunakan kembali; yang dapat mempengaruhi dinamika kontrak manufaktur (1).<\/p>\n

Apakah ini menandakan percepatan konvergensi kesehatan konsumen dan farmasi?<\/strong><\/h2>\n

Kesepakatan ini memperkuat gagasan bahwa para pemain farmasi mungkin semakin melirik pasar yang berhubungan dengan kesehatan konsumen untuk mendapatkan pertumbuhan, sehingga penting bagi tim pengembangan obat untuk memantau tren kesehatan konsumen dan jalur regulasi.<\/p>\n

Bagaimana ketahanan rantai pasokan ditinjau kembali?<\/strong><\/h2>\n

Karena akuisisi skala besar secara logis cenderung memerlukan peninjauan kembali terhadap ketahanan rantai pasokan, ekspektasi yang lebih ketat mungkin ditetapkan untuk pemasok yang menggunakan penggunaan ganda dan kemampuan penelusuran end-to-end.<\/p>\n

Singkatnya, meskipun kesepakatan Kimberly-Clark\u2013Kenvue berada di bidang kesehatan konsumen, dampaknya meluas hingga ke penemuan obat, pengembangan, dan manufaktur, yang menggarisbawahi pentingnya kesadaran lintas sektor dan strategi adaptif.<\/p>\n

Referensi<\/strong><\/h2>\n

1. Tabassum, J. dan Roy, S. Kimberly-Clark Bertaruh $40 miliar untuk Kenvue Meskipun Ada Kontroversi Tylenol.<\/astro-island> Reuters.com<\/em>3 November 2025.
2. Lavery, P. Acetaminophen dan Autisme: Dampak Industri dari Pernyataan Gedung Putih.<\/astro-island> FarmasiTech.com<\/em>23 September 2025.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Kimberly\u2011Clark mengatakan pada 3 November 2025 bahwa pihaknya berencana mengakuisisi Kenvue, bekas unit Johnson & Johnson dan pembuat merek besar Amerika Serikat seperti Band-Aid dan Tylenol, dengan nilai sekitar $48,7 miliar (1). Segera setelah pengumuman tersebut, saham Kimberly-Clark merosot tajam; Kenvue punya berada di garis bidik Menteri Kesehatan dan Layanan Kemanusiaan AS Robert F. Kennedy […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-388","post","type-post","status-publish","format-standard","hentry","category-blog"],"yoast_head":"\nKimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan - Nova Anggreni, S.Farm, APT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan - Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"og:description\" content=\"Kimberly\u2011Clark mengatakan pada 3 November 2025 bahwa pihaknya berencana mengakuisisi Kenvue, bekas unit Johnson & Johnson dan pembuat merek besar Amerika Serikat seperti Band-Aid dan Tylenol, dengan nilai sekitar $48,7 miliar (1). Segera setelah pengumuman tersebut, saham Kimberly-Clark merosot tajam; Kenvue punya berada di garis bidik Menteri Kesehatan dan Layanan Kemanusiaan AS Robert F. Kennedy […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/\" \/>\n<meta property=\"og:site_name\" content=\"Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-04T16:59:23+00:00\" \/>\n<meta name=\"author\" content=\"pythonsonline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ditulis oleh\" \/>\n\t<meta name=\"twitter:data1\" content=\"pythonsonline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/\"},\"author\":{\"name\":\"pythonsonline\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\"},\"headline\":\"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan\",\"datePublished\":\"2025-11-04T16:59:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/\"},\"wordCount\":413,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"articleSection\":[\"Blog\"],\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/\",\"url\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/\",\"name\":\"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan - Nova Anggreni, S.Farm, APT\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/#website\"},\"datePublished\":\"2025-11-04T16:59:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Beranda\",\"item\":\"https:\/\/pythonsonline.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pythonsonline.com\/#website\",\"url\":\"https:\/\/pythonsonline.com\/\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"description\":\"Keahlian Farmasi Bertemu Kekuatan Python\",\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pythonsonline.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pythonsonline.com\/#organization\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"url\":\"https:\/\/pythonsonline.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"width\":1080,\"height\":416,\"caption\":\"Nova Anggreni, S.Farm, APT\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\",\"name\":\"pythonsonline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"caption\":\"pythonsonline\"},\"sameAs\":[\"https:\/\/pythonsonline.com\"],\"url\":\"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan - Nova Anggreni, S.Farm, APT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/","og_locale":"id_ID","og_type":"article","og_title":"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan - Nova Anggreni, S.Farm, APT","og_description":"Kimberly\u2011Clark mengatakan pada 3 November 2025 bahwa pihaknya berencana mengakuisisi Kenvue, bekas unit Johnson & Johnson dan pembuat merek besar Amerika Serikat seperti Band-Aid dan Tylenol, dengan nilai sekitar $48,7 miliar (1). Segera setelah pengumuman tersebut, saham Kimberly-Clark merosot tajam; Kenvue punya berada di garis bidik Menteri Kesehatan dan Layanan Kemanusiaan AS Robert F. Kennedy […]","og_url":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/","og_site_name":"Nova Anggreni, S.Farm, APT","article_published_time":"2025-11-04T16:59:23+00:00","author":"pythonsonline","twitter_card":"summary_large_image","twitter_misc":{"Ditulis oleh":"pythonsonline","Estimasi waktu membaca":"2 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/#article","isPartOf":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/"},"author":{"name":"pythonsonline","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156"},"headline":"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan","datePublished":"2025-11-04T16:59:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/"},"wordCount":413,"commentCount":0,"publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"articleSection":["Blog"],"inLanguage":"id","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/","url":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/","name":"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan - Nova Anggreni, S.Farm, APT","isPartOf":{"@id":"https:\/\/pythonsonline.com\/#website"},"datePublished":"2025-11-04T16:59:23+00:00","breadcrumb":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/11\/04\/kimberly-clark-akan-membeli-tylenol-maker-kenvue-menganalisis-risiko-dan-imbalan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Beranda","item":"https:\/\/pythonsonline.com\/"},{"@type":"ListItem","position":2,"name":"Kimberly-Clark Akan Membeli Tylenol Maker Kenvue: Menganalisis Risiko dan Imbalan"}]},{"@type":"WebSite","@id":"https:\/\/pythonsonline.com\/#website","url":"https:\/\/pythonsonline.com\/","name":"Nova Anggreni, S.Farm, APT","description":"Keahlian Farmasi Bertemu Kekuatan Python","publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pythonsonline.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/pythonsonline.com\/#organization","name":"Nova Anggreni, S.Farm, APT","url":"https:\/\/pythonsonline.com\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","width":1080,"height":416,"caption":"Nova Anggreni, S.Farm, APT"},"image":{"@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156","name":"pythonsonline","image":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","caption":"pythonsonline"},"sameAs":["https:\/\/pythonsonline.com"],"url":"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/"}]}},"_links":{"self":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/comments?post=388"}],"version-history":[{"count":0,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/388\/revisions"}],"wp:attachment":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media?parent=388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/categories?post=388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/tags?post=388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}